Royalty Management Holding Corp (NASDAQ:RMCO) on Monday reported record second-quarter results, driven by gains from its portfolio of resource and technology investments.
Revenue for the first half of 2025 rose to $2.25 million, up 440% from $416,000 a year earlier.
Intel Corp (NASDAQ:INTC, ETR:INL) shares added more than 5% on reports its CEO Lip-Bu Tan’s scheduled visit to the White House, following a public call from President Donald Trump demanding Tan’s resignation.
According to a report by the Wall Street Journal citing unnamed sources, Tan is set to meet with Trump on Monday to discuss his personal and professional background and to explore potential areas for collaboration between Intel and the US government.
Monday.com (NASDAQ:MNDY) shares tumbled almost 27% despite the productivity software-maker’s second quarter earnings beating expectations as it issued somewhat cautious guidance for Q3.
The company's Q3 revenue guidance of about $311 to $313 million was slightly below analyst expectations at the midpoint.
Barrick Gold Corp. (TSX:ABX, NYSE:GOLD) delivered a strong second quarter earnings report, driven by sequential improvements in gold and copper production.
The company produced approximately 797,000 ounces of gold, up 5% from the prior quarter, and copper output surged 34% sequentially to 59,000 tonnes, representing a 37% increase year-over-year.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that the US Food & Drug Administration (FDA) has approved the Investigational New Drug (IND) application for its Phase 2a clinical trial of intranasal foralumab in patients with Multiple System Atrophy (MSA).
The Phase 2a study is a six-month, open-label clinical trial designed to evaluate the effects of intranasal foralumab on microglial activation, clinical outcomes, and safety in MSA patients.
American Resources Corp (NASDAQ:AREC), through its holding in ReElement Technologies, announced it has developed commercial protocols to produce germanium with purities exceeding 99.9% from both recycled and ore-based feedstocks.
The company's process is designed to supply commercial and defense markets requiring germanium products with purities ranging from 99.9% to 99.999%. Production can be sourced from virgin material or customer-provided recycled feedstock.
Micron Technology Inc (NASDAQ:MU) has updated its fiscal fourth quarter 2025 financial guidance, noting that its improved outlook reflects better pricing, particularly in DRAM, and strong execution.
The company raised its revenue forecast to $11.2 billion plus or minus $100 million, up from the prior estimate of $10.7 billion.
Versarien PLC (AIM:VRS, OTC:VRSRF) shares dropped 31% on Monday amid mounting concerns over its financial position and restructuring efforts.
The advanced engineering materials group confirmed it has begun placing key subsidiaries, including Versarien Graphene Limited, into administration or voluntary liquidation to conserve cash.
Shares in GSK PLC (LSE:GSK, NYSE:GSK) opened higher following the US Food and Drug Administration’s acceptance of gepotidacin for priority review as an oral treatment for uncomplicated urogenital gonorrhoea.
The decision, based on positive phase III data from the EAGLE-1 trial, sets a target FDA decision date of December 2025.
Shares in S4 Capital PLC (LSE:SFOR, OTC:SCPPF) jumped 10% after the media company confirmed preliminary talks to acquire marketing firm MSQ Partners.
The potential deal, if it proceeds, would see S4, founded by advertising veteran Sir Martin Sorrell, combine with MSQ, which is partially owned by US private equity group One Equity Partners.